Literature DB >> 26164571

Outpatient Chronic Obstructive Pulmonary Disease Management: Going for the GOLD.

Christina R Bellinger1, Stephen P Peters2.   

Abstract

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States with a burden of $50 billion in direct health care costs. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) defines airflow obstruction as spirometry where the ratio of forced expiratory volume in the first second to forced vital capacity after bronchodilation is less than 0.70. The guidelines also provided graded recommendations on current therapy for COPD. Treatment can be guided based on severity of disease and severity of symptoms. We review the GOLD guidelines to provide an overview of treatment modalities aimed at improving lung function, reducing hospitalization, and reducing mortality.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; Chronic obstructive pulmonary disease; GOLD guidelines

Mesh:

Year:  2015        PMID: 26164571     DOI: 10.1016/j.jaip.2015.04.010

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  9 in total

Review 1.  New combinations in the treatment of COPD: rationale for aclidinium-formoterol.

Authors:  Cristoforo Incorvaia; Marcello Montagni; Elena Makri; Erminia Ridolo
Journal:  Ther Clin Risk Manag       Date:  2016-02-15       Impact factor: 2.423

2.  Efficacy and safety of indacaterol/glycopyrronium fixed-dose combination in mild-to-moderate COPD patients symptomatic on tiotropium in Korea: study protocol for a randomized controlled trial.

Authors:  Chin Kook Rhee; Hye Yun Park; Jeong-Woong Park; Ji-Hyun Lee; Tae-Hyung Kim; Sei Won Lee; Ji Ye Jung; Song Kim; Yong Il Hwang; Ki-Suck Jung
Journal:  Trials       Date:  2017-02-22       Impact factor: 2.279

3.  Increased serum IL-17 and decreased serum IL-10 and IL-35 levels correlate with the progression of COPD.

Authors:  Shenghua Jiang; Fenglian Shan; Youwen Zhang; Luning Jiang; Zhaozhong Cheng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-20

4.  Post-discharge extended care contributes to the disease control of patients with COPD: a Chinese study.

Authors:  Min Li; Rong Hu; Xiaoyang Liu; Shuping Tao; Biaoxue Rong
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-12-14

5.  Correlation of serum levels of HIF-1α and IL-19 with the disease progression of COPD: a retrospective study.

Authors:  Biaoxue Rong; Yufang Liu; Min Li; Tian Fu; Wenlong Gao; Hua Liu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-11-21

Review 6.  The Role of Innate and Adaptive Immune Cells in the Immunopathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  Fariz Nurwidya; Triya Damayanti; Faisal Yunus
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-12-31

7.  Correlation between serum IL-32 concentration and clinical parameters of stable COPD: a retrospective clinical analysis.

Authors:  Biaoxue Rong; Tian Fu; Congxue Rong; Wen Liu; Kai Li; Hua Liu
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379

8.  Reduced Serum Concentration of CC16 Is Associated with Severity of Chronic Obstructive Pulmonary Disease and Contributes to the Diagnosis and Assessment of the Disease.

Authors:  Biaoxue Rong; Tian Fu; Wenlong Gao; Min Li; Congxue Rong; Wen Liu; Hua Liu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-03-02

9.  Association between serum CCL-18 and IL-23 concentrations and disease progression of chronic obstructive pulmonary disease.

Authors:  Biaoxue Rong; Tian Fu; Congxue Rong; Wen Liu; Kai Li; Hua Liu
Journal:  Sci Rep       Date:  2020-10-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.